Developing potent PROTACs tools for selective degradation of HDAC6 protein

Developing potent PROTACs tools for selective degradation of HDAC6 protein

Bibliographic Details
Main Authors:	Zixuan An, Wenxing Lv, Shang Su, Wei Wu, Yu Rao
Format:	Article
Language:	English
Published:	SpringerOpen 2019-01-01
Series:	Protein & Cell
Online Access:	http://link.springer.com/article/10.1007/s13238-018-0602-z

Similar Items

Correction to: Developing potent PROTACs tools for selective degradation of HDAC6 protein
by: Zixuan An, et al.
Published: (2019-02-01)

Degradation of proteins by PROTACs and other strategies
by: Yang Wang, et al.
Published: (2020-02-01)

Targeting Protein Kinases Degradation by PROTACs
by: Fei Yu, et al.
Published: (2021-06-01)

Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
by: Laura Márquez-Cantudo, et al.
Published: (2021-09-01)

Mutant-selective degradation by BRAF-targeting PROTACs
by: Shanique Alabi, et al.
Published: (2021-02-01)

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
by: Jing Liu, et al.
Published: (2021-07-01)

Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs
by: Minoru Ishikawa, et al.
Published: (2020-04-01)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
by: Si-Min Qi, et al.
Published: (2021-05-01)

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1
by: Mingxing Hu, et al.
Published: (2020-10-01)

Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
by: Mikihiko Naito, et al.
Published: (2019-12-01)

Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
by: Guoshun Luo, et al.
Published: (2021-05-01)

Tubulin Resists Degradation by Cereblon-Recruiting PROTACs
by: Ivana Gasic, et al.
Published: (2020-04-01)

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
by: Xin Li, et al.
Published: (2020-05-01)

Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells
by: Huapeng Zhang, et al.
Published: (2020-01-01)

Degrading AR-Dependent Cancers: Expanding the Role of PROTACs
by: Anna R. Michmerhuizen, et al.
Published: (2020-10-01)

Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy
by: Minghua Yuan, et al.
Published: (2021-07-01)

From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
by: Carlotta Cecchini, et al.
Published: (2021-04-01)

Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
by: Darwish, S., et al.
Published: (2022)

Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog—Thalidomide PROTACs
by: Ga-Yeong Kim, et al.
Published: (2021-04-01)

FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice
by: Hongying Gao, et al.
Published: (2020-05-01)

First small-molecule PROTACs for G protein-coupled receptors: inducing α1A-adrenergic receptor degradation
by: Zhenzhen Li, et al.
Published: (2020-09-01)

Development of biophysical methods for characterization of PROTACs
by: Oskar, Westlin
Published: (2021)

Are we ready to design oral PROTACs®?
by: Diego Garcia Jimenez, et al.
Published: (2021-08-01)

A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo
by: Lijie Zhao, et al.
Published: (2020-10-01)

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
by: Yuan Fang, et al.
Published: (2020-07-01)

Photocontrollable PROTAC molecules: Structure and mechanism of action
by: Koravović Mladen, et al.
Published: (2021-01-01)

Proteolysis targeting chimeras (PROTACs) in cancer therapy
by: Alberto Ocaña, et al.
Published: (2020-09-01)

Novel approaches for the rational design of PROTAC linkers
by: Almaz Zagidullin, et al.
Published: (2020-10-01)

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
by: Shuiyan Wu, et al.
Published: (2021-04-01)

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
by: Yonghan He, et al.
Published: (2020-07-01)

Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation
by: Ming He, et al.
Published: (2021-06-01)

Specific MHC-I Peptides Are Induced Using PROTACs
by: Stephanie M. Jensen, et al.
Published: (2018-11-01)

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
by: Chiara Maniaci, et al.
Published: (2017-10-01)

Design, Synthesis, and Biological Evaluation of Proteolysis Targeting Chimeras (PROTACs) for the Dual Degradation of IGF-1R and Src
by: Sudhakar Manda, et al.
Published: (2020-04-01)

Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
by: Nicoló Tonali, et al.
Published: (2021-01-01)

2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury.
by: Jing Liu, et al.
Published: (2019-01-01)

Selective HDAC6 Inhibition in Systemic Lupus Erythematosus
by: Vieson, Miranda Diane
Published: (2017)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
by: Hany S. Ibrahim, et al.
Published: (2021-07-01)

Exploring the Ubiquitin-Proteasome System (UPS) through PROTAC Technology
by: Carlotta Cecchini, et al.
Published: (2020-04-01)

Current strategies for the design of PROTAC linkers: a critical review
by: Robert I. Troup, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_i834elfckoek7su733c0qsvs9e